FDA Drug Enforcement — Foreign Manufacturer Recalls (FDA-FE)

FDA Drug Enforcement — Foreign Manufacturer Recalls is the official source of medicine shortage information for United States (Americas). Mederti checks its register regularly and links every notice back to the original publication.

Official register

www.accessdata.fda.gov

Country

United States

Notices tracked by Mederti

220

Last checked

16 Sept 2026

Latest notices from FDA-FE

• Tadalafil — active, high, since 3 Aug 2026 (source)
• Sildenafilo Aristo — active, high, since 3 Aug 2026 (source)
• Pemetrexed Disodium — active, high, since 29 Jul 2026 (source)
• Cyclophosphamide-Monohydrate — active, critical, since 17 Jul 2026 (source)
• Naphazoline Hydrochloride — active, high, since 14 Jul 2026 (source)
• Povidone-Iodine/Lidocaine/Tetracaine 4.6%/4%/0.5% Ophthalmic — active, high, since 14 Jul 2026 (source)
• Hypromellose 2906 (4000 Mpa.S) — active, high, since 14 Jul 2026 (source)
• Rohto Cooling Eye Drops — active, high, since 14 Jul 2026 (source)
• Bortezomibmannitol — active, high, since 24 Jun 2026 (source)
• Pemetrexed-Disodium — active, high, since 24 Jun 2026 (source)
• Cetirizine Hydrochloride — active, critical, since 24 Jun 2026 (source)
• Azacitidine Accord 25 Mg / Ml Powder For Suspension For Injection (Azacitidine) — active, high, since 24 Jun 2026 (source)
• Methohexital (Brevital Sodium) 10 Mg/Ml — active, high, since 7 Jun 2026 (source)
• Chlorthalidone — active, high, since 5 Jun 2026 (source)
• Lacosamide — active, high, since 4 Jun 2026 (source)

Mederti is not affiliated with or endorsed by FDA Drug Enforcement — Foreign Manufacturer Recalls. All notices remain the property of their publisher and are linked to the original source.